TESORX Trademark

Trademark Overview

On Wednesday, October 22, 2014, a trademark application was filed for TESORX with the United States Patent and Trademark Office. The USPTO has given the TESORX trademark a serial number of 86431639. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Wednesday, July 26, 2023. This trademark is owned by Tesorx Pharma, LLC. The TESORX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical drug development services; pharmaceutical products development; pharmaceutical research and development; pharmaceutical research services
tesorx

General Information

Serial Number86431639
Word MarkTESORX
Filing DateWednesday, October 22, 2014
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateWednesday, July 26, 2023
Registration Number5131036
Registration DateTuesday, January 31, 2017
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 15, 2016

Trademark Statements

Description of MarkThe mark consists of the wording "TESORX" in stylized font whereby a curved line appears above the letter "O".
Pseudo MarkTESO RX
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesPharmaceutical drug development services; pharmaceutical products development; pharmaceutical research and development; pharmaceutical research services

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, October 30, 2014
Primary Code042
First Use Anywhere DateFriday, April 30, 2010
First Use In Commerce DateFriday, April 30, 2010

Trademark Owner History

Party NameTesorx Pharma, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressMenlo Park, CA 940256805
Party NameTesorx Pharma, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressMenlo Park, CA 940256805
Party NameTesorx Pharma, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressMenlo Park, CA 940256805

Trademark Events

Event DateEvent Description
Wednesday, July 26, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, July 26, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, July 26, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, January 31, 2023TEAS SECTION 8 & 15 RECEIVED
Monday, January 31, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, January 31, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, November 15, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 15, 2016PUBLISHED FOR OPPOSITION
Wednesday, October 26, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 11, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, October 5, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 8, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, July 8, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 5, 2016REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, September 29, 2015NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, September 29, 2015LETTER OF SUSPENSION E-MAILED
Tuesday, September 29, 2015SUSPENSION LETTER WRITTEN
Wednesday, September 9, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 9, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 2, 2015ASSIGNED TO LIE
Tuesday, August 18, 2015TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, August 18, 2015REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, February 18, 2015NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, February 18, 2015LETTER OF SUSPENSION E-MAILED
Wednesday, February 18, 2015SUSPENSION LETTER WRITTEN
Wednesday, February 18, 2015EXAMINER'S AMENDMENT ENTERED
Wednesday, February 18, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, February 18, 2015EXAMINERS AMENDMENT E-MAILED
Wednesday, February 18, 2015EXAMINERS AMENDMENT -WRITTEN
Tuesday, February 10, 2015ASSIGNED TO EXAMINER
Friday, October 31, 2014NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, October 30, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 27, 2014NEW APPLICATION ENTERED

Related Keywords

tesorx pharmaceutical development research services drug products